Marco Meglio, Editor for NeurologyLive, has been with the team since October 2019. Follow him on Twitter @marcomeglio1 or email him at mmeglio@neurologylive.com
Here Comes the Sun: AASM Backs Senate’s Decision to Abolish Daylight Saving Time
March 18th 2022The American Academy of Sleep Medicine has previously pointed to evidence showing that the sudden change from standard time to daylight saving time is associated with significant public health, safety risks, and circadian rhythm.
NeuroVoices: Jiwon Oh, MD, PhD, on Radiologically Isolated Syndrome as a Precursor to MS
March 9th 2022The staff neurologist and medical director of the Barlo Multiple Sclerosis Program at St Michaels Hospital provided insight on the use of biomarkers to improve management of RIS and uncover more as it relates to MS.
FAMI Questionnaire Shows Positive Results as Tool to Assess Migraine Attack-Related Fear
March 7th 2022Factors such as fear of negative consequences, attention and anticipation, and fear-avoidances were identified using the newly developed Fear of Attacks in Migraine Inventory questionnaire, which may have use in clinical settings.
Large-Scale Meta-Analysis Further Emphasizes Greater Functional Outcomes With Mobile Stroke Units
March 6th 2022Mobile stroke units led to a higher proportion of intravenous thrombolysis among patients with acute ischemic stroke, of whom up to one-third were treated within 60 minutes of symptom onset.
COVID-19 Vaccine Booster Increases Protective Effects of Anti-CD20 Therapy in Patients With MS
March 5th 2022A third dose enhanced the number of responders to all variants and significantly increased CD8 T-cell responses, but the frequencies of Omicron-specific CD8 T-cells remained 70% of the responses specific to the vaccine strain.